当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 现金流量表

复星医药

(600196)

  

流通市值:578.14亿  总市值:729.01亿
流通股本:21.18亿   总股本:26.71亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金30,140,941,020.1919,939,164,414.429,824,877,278.4842,392,553,570.17
收到的税费返还396,176,187.19230,414,610.43106,375,698.71441,829,818.51
收到其他与经营活动有关的现金1,014,810,121.01575,493,793.37369,397,090.491,531,520,703.14
经营活动现金流入的平衡项目0000
经营活动现金流入小计31,551,927,328.3920,745,072,818.2210,300,650,067.6844,365,904,091.82
购买商品、接受劳务支付的现金11,113,466,213.167,067,198,571.363,387,898,596.3217,011,031,089.23
支付给职工以及为职工支付的现金8,472,222,959.745,888,679,822.093,129,381,997.210,603,925,695.2
支付的各项税费1,845,379,714.81,344,936,192.55640,089,622.642,819,368,483.25
支付其他与经营活动有关的现金7,134,221,085.524,537,254,334.222,225,967,746.4910,517,361,760.55
经营活动现金流出的平衡项目0000
经营活动现金流出小计28,565,289,973.2218,838,068,920.229,383,337,962.6540,951,687,028.23
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额2,986,637,355.171,907,003,898917,312,105.033,414,217,063.59
二、投资活动产生的现金流量:
收回投资收到的现金334,148,666.439,146,222.0319,396,578.041,860,266,269.95
取得投资收益收到的现金1,019,256,256.61235,720,364.91138,607,795.3949,058,570.81
处置固定资产、无形资产和其他长期资产收回的现金净额238,760,527.638,705,904.261,170,123.539,009,442.18
处置子公司及其他营业单位收到的现金净额138,522,994.25134,053,430.37138,268,977.45300,000
收到的其他与投资活动有关的现金93,073,923.2398,375,301.9479,491,631.81934,806,317.04
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,823,762,368.12516,001,223.51376,935,106.133,753,440,599.98
购建固定资产、无形资产和其他长期资产支付的现金3,026,949,825.292,093,357,052.051,254,450,607.885,336,704,753.14
投资支付的现金931,718,461.75638,038,447.737,181,529.25942,970,606.95
取得子公司及其他营业单位支付的现金-41,979,707.88-923,998,933.12
支付其他与投资活动有关的现金304,806,549.95392,574,930.06276,434,134.54369,056,679.19
投资活动现金流出的平衡项目0000
投资活动现金流出小计4,263,474,836.993,165,950,137.691,568,066,271.677,572,730,972.4
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-2,439,712,468.87-2,649,948,914.18-1,191,131,165.54-3,819,290,372.42
三、筹资活动产生的现金流量:
吸收投资收到的现金168,075,471.89106,070,436.32114,182,753.6876,629,839.47
其中:子公司吸收少数股东投资收到的现金168,075,471.89106,070,436.32114,182,753.6876,629,839.47
取得借款收到的现金21,739,468,572.5915,874,396,007.467,989,226,244.5923,175,941,310.81
收到其他与筹资活动有关的现金2,057,595,013.831,932,789,359.0174,615,613.82337,726,713.85
筹资活动现金流入平衡项目0000
筹资活动现金流入小计23,965,139,058.3117,913,255,802.798,178,024,612.0923,590,297,864.13
偿还债务支付的现金21,800,975,343.7715,728,585,194.37,630,293,087.8921,146,225,034.46
分配股利、利润或偿付利息支付的现金2,053,832,098.21846,641,558.79344,870,822.692,659,692,519.96
其中:子公司支付给少数股东的股利、利润354,336,577.14182,018,449.2613,489,521.08204,522,791.93
支付其他与筹资活动有关的现金612,621,029.02247,464,873.84104,223,077.911,120,630,108.57
筹资活动现金流出平衡项目0000
筹资活动现金流出小计24,467,428,47116,822,691,626.938,079,386,988.4924,926,547,662.99
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-502,289,412.691,090,564,175.8698,637,623.6-1,336,249,798.86
四、汇率变动对现金及现金等价物的影响-69,635,970.1417,131,450.2123,437,769.8973,645,025.18
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-25,000,496.53364,750,609.89-151,743,667.02-1,667,678,082.51
加:期初现金及现金等价物余额9,502,388,906.049,502,388,906.049,502,388,906.0411,170,066,988.55
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额9,477,388,409.519,867,139,515.939,350,645,239.029,502,388,906.04
补充资料:
净利润-1,549,731,977.11-2,895,063,426.58
资产减值准备-58,211,200.4-351,669,556.67
固定资产和投资性房地产折旧-741,754,366.29-1,364,242,812.55
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-741,754,366.29-1,364,242,812.55
无形资产摊销-523,338,046.4-1,334,550,719.25
长期待摊费用摊销-79,783,373.63-153,493,799.99
处置固定资产、无形资产和其他长期资产的损失--716,943.9--5,563,773.63
固定资产报废损失-1,223,970.55-5,025,297.02
公允价值变动损失-282,397,883.66-427,379,582.37
财务费用-623,109,420.59-1,169,251,842.36
投资损失--1,061,766,335.39--3,501,992,600.27
递延所得税--82,230,621.41--144,605,377.84
其中:递延所得税资产减少--35,681,035.26--35,259,676.92
递延所得税负债增加--46,549,586.15--109,345,700.92
存货的减少--5,741,136.31--333,906,025.12
经营性应收项目的减少--269,894,611.21-1,605,091,918.04
经营性应付项目的增加--715,515,225.74--2,207,773,349.94
现金的期末余额-9,867,139,515.93-9,502,388,906.04
减:现金的期初余额-9,502,388,906.04-11,170,066,988.55
公告日期2024-10-302024-08-282024-04-302024-03-27
审计意见(境内)标准无保留意见
TOP↑